Market research
015540.KO THELMA Therapeutics Co., Ltd
KO KRW Not available
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 339B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.09
Community
Investor discussion
1 comment
Sign in to join the 015540.KO discussion.
5 years, 5 months ago
THELMA Therapeutics Co., Ltd is currently in a long term downtrend where the price is trading 9.5% below its 200 day moving average.
From a valuation standpoint, the stock is 642.5% more expensive than other stocks from the Industrials sector with a price to sales ratio of 7.0.
THELMA Therapeutics Co., Ltd's total revenue rose by 0.9% to $2B since the same quarter in the previous year.
Its net income has increased by 32.3% to $-8B since the same quarter in the previous year.
Finally, its free cash flow grew by 54.8% to $-2B since the same quarter in the previous year.
Based on the above factors, THELMA Therapeutics Co., Ltd gets an overall score of 3/5.